This document provides an overview of epilepsies and antiepileptic drugs (AEDs). It defines epilepsy as a brain disorder characterized by recurrent seizures. Seizures are caused by abnormal electrical discharges in the brain. The document classifies seizures as partial or generalized, discusses the neurobiology and diagnosis of epilepsy, and outlines various AEDs used to treat different types of seizures. It also addresses the economic and social implications of epilepsy, and provides an introduction to the author's research on the essential oil of Curcuma longa and its neuropharmacological effects in mice.
Animal models for screening of antiepileptic drugs &kamal_1981
The document outlines screening methods for antiepileptic drugs and their recent advances. It discusses various in vivo and in vitro methods used to screen drugs for ability to prevent seizures induced electrically or chemically in animal models. Recent advances include newer drugs like lamotrigine, topiramate, felbamate, zonisamide, vigabatrin, tiagabine, gabapentin, lacosamide, and levetiracetam that target sodium channels, glutamate receptors, GABA receptors or uptake to suppress seizure activity.
Epilepsy is a chronic neurological disorder characterized by recurrent seizures. It affects approximately 1% of the population globally. Seizures occur due to an imbalance between excitatory and inhibitory neurotransmitters in the brain. Epilepsy is classified based on the origin of abnormal neuronal discharges as either focal or generalized seizures. Treatment involves pharmacotherapy with anti-epileptic drugs such as sodium channel blockers, calcium channel modulators, and GABA analogues to suppress seizure activity and control symptoms.
1. Epilepsy, Seizure, Convulsion
2. Causes & Pathophysiology of Epilepsy
3. Classification and Choice of antiepileptics
4. Antiepileptics Mechanism of action of , Adverse effects, Drug interactions, General guidelines for use.
5. Recommendation to Antiepileptics and pregnancy according to RCOG 2016, SIGN 2017 guidelines
6. Treatment of status epilepticus according to American Epilepsy Society 2016 guidelines
The autonomic nervous system (ANS) carries nerve impulses from the central nervous system to effector organs via two types of neurons - preganglionic and postganglionic. Preganglionic neurons originate in the CNS and synapse in peripheral ganglia, while postganglionic neurons innervate effector organs. Acetylcholine is the main neurotransmitter of the parasympathetic division and some parts of the sympathetic division. It is synthesized locally and broken down by acetylcholinesterase. Cholinergic drugs like pilocarpine and edrophonium act by either directly activating cholinergic receptors or indirectly by inhibiting acetylcholinesterase. Atropine is a competitive mus
Pain is a complex experience involving both sensory and emotional components. There are various scales used to measure pain. The main options for pain treatment are analgesics which can be opioids or non-opioids. Opioids include natural, semi-synthetic, and synthetic compounds that act on opioid receptors in the brain to reduce pain perception and emotional response to pain. Non-opioids like NSAIDs inhibit prostaglandin synthesis to reduce inflammation and pain. Common NSAIDs include aspirin, ibuprofen, and paracetamol.
This document provides information on seizure disorder (epilepsy). It defines seizures and epilepsy, describes different types of seizures including partial and generalized seizures. It discusses causes, risk factors, pathophysiology, diagnostic assessment including EEG and imaging, management with anticonvulsant medications, surgical options, nursing care to prevent injury and maintain airway/breathing, nursing diagnoses, and complications. Prognosis is discussed, noting 50 million people worldwide live with epilepsy, with 10 million in India, and treatment gaps remain in developing countries.
The document reports on a project to investigate the analgesic activity of the aqueous fruit extract of Tribulus terristris in rats. Key findings include:
- Phytochemical screening of the extract found alkaloids, flavonoids, triterpenoids and other compounds.
- Analgesic activity was evaluated using the Eddy's hot plate and acetic acid-induced writhing models. The extract showed analgesic effects in a dose-dependent manner.
- The study aims to provide evidence of the analgesic potential of T. terristris extract and its various phytochemical constituents.
Animal models for screening of antiepileptic drugs &kamal_1981
The document outlines screening methods for antiepileptic drugs and their recent advances. It discusses various in vivo and in vitro methods used to screen drugs for ability to prevent seizures induced electrically or chemically in animal models. Recent advances include newer drugs like lamotrigine, topiramate, felbamate, zonisamide, vigabatrin, tiagabine, gabapentin, lacosamide, and levetiracetam that target sodium channels, glutamate receptors, GABA receptors or uptake to suppress seizure activity.
Epilepsy is a chronic neurological disorder characterized by recurrent seizures. It affects approximately 1% of the population globally. Seizures occur due to an imbalance between excitatory and inhibitory neurotransmitters in the brain. Epilepsy is classified based on the origin of abnormal neuronal discharges as either focal or generalized seizures. Treatment involves pharmacotherapy with anti-epileptic drugs such as sodium channel blockers, calcium channel modulators, and GABA analogues to suppress seizure activity and control symptoms.
1. Epilepsy, Seizure, Convulsion
2. Causes & Pathophysiology of Epilepsy
3. Classification and Choice of antiepileptics
4. Antiepileptics Mechanism of action of , Adverse effects, Drug interactions, General guidelines for use.
5. Recommendation to Antiepileptics and pregnancy according to RCOG 2016, SIGN 2017 guidelines
6. Treatment of status epilepticus according to American Epilepsy Society 2016 guidelines
The autonomic nervous system (ANS) carries nerve impulses from the central nervous system to effector organs via two types of neurons - preganglionic and postganglionic. Preganglionic neurons originate in the CNS and synapse in peripheral ganglia, while postganglionic neurons innervate effector organs. Acetylcholine is the main neurotransmitter of the parasympathetic division and some parts of the sympathetic division. It is synthesized locally and broken down by acetylcholinesterase. Cholinergic drugs like pilocarpine and edrophonium act by either directly activating cholinergic receptors or indirectly by inhibiting acetylcholinesterase. Atropine is a competitive mus
Pain is a complex experience involving both sensory and emotional components. There are various scales used to measure pain. The main options for pain treatment are analgesics which can be opioids or non-opioids. Opioids include natural, semi-synthetic, and synthetic compounds that act on opioid receptors in the brain to reduce pain perception and emotional response to pain. Non-opioids like NSAIDs inhibit prostaglandin synthesis to reduce inflammation and pain. Common NSAIDs include aspirin, ibuprofen, and paracetamol.
This document provides information on seizure disorder (epilepsy). It defines seizures and epilepsy, describes different types of seizures including partial and generalized seizures. It discusses causes, risk factors, pathophysiology, diagnostic assessment including EEG and imaging, management with anticonvulsant medications, surgical options, nursing care to prevent injury and maintain airway/breathing, nursing diagnoses, and complications. Prognosis is discussed, noting 50 million people worldwide live with epilepsy, with 10 million in India, and treatment gaps remain in developing countries.
The document reports on a project to investigate the analgesic activity of the aqueous fruit extract of Tribulus terristris in rats. Key findings include:
- Phytochemical screening of the extract found alkaloids, flavonoids, triterpenoids and other compounds.
- Analgesic activity was evaluated using the Eddy's hot plate and acetic acid-induced writhing models. The extract showed analgesic effects in a dose-dependent manner.
- The study aims to provide evidence of the analgesic potential of T. terristris extract and its various phytochemical constituents.
This document provides information on antiepileptic drugs (AEDs). It defines epilepsy and different types including generalized and partial seizures. It discusses the classification and mechanisms of action of AEDs including effects on sodium channels, GABA neurotransmission, and calcium channels. Specific AEDs described in detail include phenytoin, carbamazepine, oxcarbazepine, and eslicarbazepine. Their indications, mechanisms, adverse effects, drug interactions and important notes are summarized. Carbamazepine is also described as the drug of choice for treating trigeminal neuralgia.
Explanation of Preclinical (Animal) Models of Seizure and Epilepsy.
General overview of Seizure and Epilepsy and its current Management. Need to develop newer drugs and Newer models. Current models for Acute Seizure. Kindling explained. PPT contains overview and Protocol.
This document provides an overview of seizure disorders including basics, epidemiology, risk factors, pathophysiology, diagnosis, treatment, and prognosis. Some key points:
- Seizures are caused by excessive firing of neurons resulting in impaired brain function. Common causes include brain tumors, head injuries, infections, genetic factors.
- Around 200,000 new cases of epilepsy are diagnosed in the US each year, most commonly in children under 15 and older adults over 65.
- Diagnosis involves differentiating epileptic from non-epileptic seizures based on eyewitness accounts and EEG/MRI testing. Initial lab work checks for metabolic causes.
- Treatment primarily involves anti-epileptic medications chosen based
Advances in management of seizure disorderShadab Ahmad
Seizure- a paroxysmal event due to abnormal
excessive or synchronous neuronal activity
in the brain.
Epilepsy- Recurrent seizure due to chronic
underlying process.
1. The document discusses various types of poisonings including acetaminophen, organophosphates, opioids, antidepressants, and carbon monoxide. It covers the mechanisms, clinical findings, diagnosis, and management for each type.
2. Key aspects of management for all poisonings include decontamination, supportive care, and antidotes when available to counteract the poison. Specific poisonings require targeted treatments like N-acetylcysteine for acetaminophen or naloxone for opioids.
3. Differentiation of poisonings can be made based on physical findings and toxic syndromes. Outcomes depend on prompt identification and treatment of the poisoning and progression of toxic effects.
Anti epileptic agents or drugs pharmacologysonalinghatmal
This document summarizes information about antiepileptic drugs used to treat epilepsy. It discusses the pathophysiology of epilepsy, how it is diagnosed, and classifications of antiepileptic drugs. It then focuses on the pharmacology of phenytoin, an antiepileptic drug, covering its mechanism of action, pharmacokinetics, uses, adverse effects and drug interactions. Phenytoin works by stabilizing neuronal membranes and modifying the body's normal response to seizures. It has a wide range of adverse effects and interacts with many other drugs by inducing or inhibiting liver enzymes.
This document summarizes various in vitro and in vivo models used for anti-epileptic drug screening. The in vitro models described include tests measuring effects on GABA and glutamate receptors, transporters, and uptake/release. The in vivo models involve inducing seizures chemically or through focal lesions in rodents and examining effects of test compounds. Several genetic and transgenic animal models of epilepsy are also mentioned. The document provides details on procedures and evaluation methods for key screening tests involving GABA uptake/release in hippocampal slices and electroshock induction in mice.
INVESTIGATION THE EFFECT OF PENTHYLENTETRAZOLE INDUCING EPILEPSY MODEL USING ...Self-employed researcher
This study investigated the anticonvulsant effects of Epilobium hirsutum extract in a pentylenetetrazole (PTZ)-induced seizure model in mice. Mice were pretreated with 100 or 200 mg/kg of E. hirsutum extract or valproate before being injected with PTZ. The extract increased seizure onset time and decreased duration compared to the PTZ group. Neurological tests and biochemical assays also showed the extract reduced oxidative stress and improved motor function versus PTZ. The results suggest E. hirsutum has anticonvulsant properties potentially due to its antioxidant compounds like flavonoids and phenolic acids.
INTRODUCTION
HISTORY
MECHANISM OF ACTION
INDICATION OF ECT
TYPES OF ECT
ELECTRIC STIMULUS
DURATION OF THERAPY
PRE TREATMENT EVALUATION
CONTRAINDICATION
SIDE EFFECT
ELECTROD REPLACEMENT
ROLE OF NURSES
DOCUMENTATION
SUMMARY
This document provides an overview of epilepsy including its etiology, epidemiology, pathophysiology, clinical manifestations, diagnosis, treatment, and management. Some key points include: Epilepsy is characterized by recurrent seizures and can be caused by genetic or acquired factors in approximately 30% of cases. It affects about 50 per 100,000 people. Abnormalities in ion channels or inhibitory/excitatory neurotransmission in the brain lead to seizures. Treatment involves anti-seizure medications to modulate ion channels or inhibitory neurotransmission as well as non-pharmacological options like the ketogenic diet or neurostimulation devices for treatment-resistant cases.
This document discusses various psychopharmacological agents used to treat psychiatric conditions including antipsychotics, antidepressants, mood stabilizers, and benzodiazepines. It provides details on the classification, mechanisms of action, indications, and adverse effects of typical and atypical antipsychotics, tricyclic and SSRI antidepressants, lithium and anticonvulsants used as mood stabilizers. It emphasizes the importance of monitoring serum lithium levels and describes the management of lithium toxicity as an emergency. The document aims to inform psychiatrists and other medical professionals about appropriate pharmacotherapy options for different psychiatric diagnoses.
The document discusses various treatment modalities in psychiatry including somatic (physical) therapies like psychopharmacology, electroconvulsive therapy, and psychosurgery. It provides details on specific psychotropic drugs like antipsychotics, antidepressants, mood stabilizers, anxiolytics, and their indications, mechanisms of action, dosages, side effects and the nurse's role in administering them. Electroconvulsive therapy is described as the artificial induction of seizures through electrical stimulation to treat severe depression, catatonia and psychosis.
A 55-year-old man was found unconscious at home after ingesting kratom and alcohol. At the emergency department, he was comatose with low vital signs. Treatment with naloxone had no effect. He was given supportive care and woke up 10 hours later, admitting to ingesting kratom and whiskey. Kratom contains compounds that are opioid receptor agonists and can cause respiratory depression, especially in combination with alcohol. Supportive care is the primary treatment for kratom toxicity.
A 55-year-old man was found unconscious at home after ingesting kratom and alcohol. At the emergency department, he was comatose with low vital signs. Treatment with naloxone had no effect. He was given supportive care and woke up 10 hours later, admitting to ingesting kratom and whiskey. Kratom contains compounds that are opioid receptor agonists and can cause respiratory depression, especially in combination with other depressants like alcohol.
The document defines syncope as a transient loss of consciousness due to decreased blood flow to the brain. It classifies syncope into cardiac, reflex/neurocardiogenic, and orthostatic hypotension categories based on etiology. Cardiac syncope can be due to arrhythmias like bradycardia or structural issues like aortic stenosis. Reflex syncope includes vasovagal which can be triggered by emotions or orthostatic stress, and carotid sinus syncope caused by pressure on the carotid sinus. Orthostatic hypotension syncope results from autonomic dysfunction or drugs/illnesses that cause volume depletion.
This document summarizes several experimental animal models used to study seizures and epilepsy. It discusses:
1. Classification of seizures and characteristics of ideal seizure models.
2. Common generalized seizure models including maximal electroshock, pentylenetetrazole, and picrotoxin induced seizures.
3. Models of partial seizures including those induced by topical convulsants, electrical stimulation, and chronic metal implants.
4. Genetic models like photosensitive baboons and audiogenic seizure prone mice strains.
It provides details on methodology, evaluation, and drugs effective in each model. The document aims to describe preclinical tools used in anticonvulsant drug development and mechanistic epilepsy
This document provides an overview of pain management including definitions, classifications, clinical assessment, and various treatment options. It begins with defining acute and chronic pain and outlining the pain pathway. It then discusses taking a history, performing an exam, and ordering investigations to clinically assess pain. Finally, it details the WHO analgesic ladder and various pharmacological and non-pharmacological options for controlling pain, such as oral and parenteral analgesics, adjuvant therapies, and managing side effects.
DENTAL MANAGEMENTS OF PATIENTS WITH GASTROINTESTINAL DISEASE (2).pptxSamuelAgboola11
This document discusses the dental management of patients with various gastrointestinal diseases. It begins by describing the anatomy and functions of the gastrointestinal tract. It then discusses several gastrointestinal diseases including GERD, hiatal hernia, peptic ulcer, inflammatory bowel disease (Crohn's disease and ulcerative colitis), liver cirrhosis, and eating disorders. For each condition, it describes oral manifestations that may be seen and precautions that should be taken during dental treatment. Throughout, it emphasizes the need for dentists to accommodate a patient's underlying systemic disease, avoid drug interactions, and minimize stress when providing care.
DENTAL MANAGEMENT OF PATIENTS WITH REPIRATORY DISEASES 2809-1.pptxSamuelAgboola11
This document discusses the relationship between the respiratory and oral systems. It begins by describing the structures and functions of the respiratory system, including the conducting airways, lungs, muscles of respiration, and control centers in the central nervous system. It then discusses several respiratory diseases like viral upper respiratory infections, asthma, pneumonia, and tuberculosis. For each disease, it covers signs and symptoms, pathogenesis, and dental management considerations. The document emphasizes the importance of oral health in preventing respiratory infections and managing patients with respiratory diseases.
This document provides information on antiepileptic drugs (AEDs). It defines epilepsy and different types including generalized and partial seizures. It discusses the classification and mechanisms of action of AEDs including effects on sodium channels, GABA neurotransmission, and calcium channels. Specific AEDs described in detail include phenytoin, carbamazepine, oxcarbazepine, and eslicarbazepine. Their indications, mechanisms, adverse effects, drug interactions and important notes are summarized. Carbamazepine is also described as the drug of choice for treating trigeminal neuralgia.
Explanation of Preclinical (Animal) Models of Seizure and Epilepsy.
General overview of Seizure and Epilepsy and its current Management. Need to develop newer drugs and Newer models. Current models for Acute Seizure. Kindling explained. PPT contains overview and Protocol.
This document provides an overview of seizure disorders including basics, epidemiology, risk factors, pathophysiology, diagnosis, treatment, and prognosis. Some key points:
- Seizures are caused by excessive firing of neurons resulting in impaired brain function. Common causes include brain tumors, head injuries, infections, genetic factors.
- Around 200,000 new cases of epilepsy are diagnosed in the US each year, most commonly in children under 15 and older adults over 65.
- Diagnosis involves differentiating epileptic from non-epileptic seizures based on eyewitness accounts and EEG/MRI testing. Initial lab work checks for metabolic causes.
- Treatment primarily involves anti-epileptic medications chosen based
Advances in management of seizure disorderShadab Ahmad
Seizure- a paroxysmal event due to abnormal
excessive or synchronous neuronal activity
in the brain.
Epilepsy- Recurrent seizure due to chronic
underlying process.
1. The document discusses various types of poisonings including acetaminophen, organophosphates, opioids, antidepressants, and carbon monoxide. It covers the mechanisms, clinical findings, diagnosis, and management for each type.
2. Key aspects of management for all poisonings include decontamination, supportive care, and antidotes when available to counteract the poison. Specific poisonings require targeted treatments like N-acetylcysteine for acetaminophen or naloxone for opioids.
3. Differentiation of poisonings can be made based on physical findings and toxic syndromes. Outcomes depend on prompt identification and treatment of the poisoning and progression of toxic effects.
Anti epileptic agents or drugs pharmacologysonalinghatmal
This document summarizes information about antiepileptic drugs used to treat epilepsy. It discusses the pathophysiology of epilepsy, how it is diagnosed, and classifications of antiepileptic drugs. It then focuses on the pharmacology of phenytoin, an antiepileptic drug, covering its mechanism of action, pharmacokinetics, uses, adverse effects and drug interactions. Phenytoin works by stabilizing neuronal membranes and modifying the body's normal response to seizures. It has a wide range of adverse effects and interacts with many other drugs by inducing or inhibiting liver enzymes.
This document summarizes various in vitro and in vivo models used for anti-epileptic drug screening. The in vitro models described include tests measuring effects on GABA and glutamate receptors, transporters, and uptake/release. The in vivo models involve inducing seizures chemically or through focal lesions in rodents and examining effects of test compounds. Several genetic and transgenic animal models of epilepsy are also mentioned. The document provides details on procedures and evaluation methods for key screening tests involving GABA uptake/release in hippocampal slices and electroshock induction in mice.
INVESTIGATION THE EFFECT OF PENTHYLENTETRAZOLE INDUCING EPILEPSY MODEL USING ...Self-employed researcher
This study investigated the anticonvulsant effects of Epilobium hirsutum extract in a pentylenetetrazole (PTZ)-induced seizure model in mice. Mice were pretreated with 100 or 200 mg/kg of E. hirsutum extract or valproate before being injected with PTZ. The extract increased seizure onset time and decreased duration compared to the PTZ group. Neurological tests and biochemical assays also showed the extract reduced oxidative stress and improved motor function versus PTZ. The results suggest E. hirsutum has anticonvulsant properties potentially due to its antioxidant compounds like flavonoids and phenolic acids.
INTRODUCTION
HISTORY
MECHANISM OF ACTION
INDICATION OF ECT
TYPES OF ECT
ELECTRIC STIMULUS
DURATION OF THERAPY
PRE TREATMENT EVALUATION
CONTRAINDICATION
SIDE EFFECT
ELECTROD REPLACEMENT
ROLE OF NURSES
DOCUMENTATION
SUMMARY
This document provides an overview of epilepsy including its etiology, epidemiology, pathophysiology, clinical manifestations, diagnosis, treatment, and management. Some key points include: Epilepsy is characterized by recurrent seizures and can be caused by genetic or acquired factors in approximately 30% of cases. It affects about 50 per 100,000 people. Abnormalities in ion channels or inhibitory/excitatory neurotransmission in the brain lead to seizures. Treatment involves anti-seizure medications to modulate ion channels or inhibitory neurotransmission as well as non-pharmacological options like the ketogenic diet or neurostimulation devices for treatment-resistant cases.
This document discusses various psychopharmacological agents used to treat psychiatric conditions including antipsychotics, antidepressants, mood stabilizers, and benzodiazepines. It provides details on the classification, mechanisms of action, indications, and adverse effects of typical and atypical antipsychotics, tricyclic and SSRI antidepressants, lithium and anticonvulsants used as mood stabilizers. It emphasizes the importance of monitoring serum lithium levels and describes the management of lithium toxicity as an emergency. The document aims to inform psychiatrists and other medical professionals about appropriate pharmacotherapy options for different psychiatric diagnoses.
The document discusses various treatment modalities in psychiatry including somatic (physical) therapies like psychopharmacology, electroconvulsive therapy, and psychosurgery. It provides details on specific psychotropic drugs like antipsychotics, antidepressants, mood stabilizers, anxiolytics, and their indications, mechanisms of action, dosages, side effects and the nurse's role in administering them. Electroconvulsive therapy is described as the artificial induction of seizures through electrical stimulation to treat severe depression, catatonia and psychosis.
A 55-year-old man was found unconscious at home after ingesting kratom and alcohol. At the emergency department, he was comatose with low vital signs. Treatment with naloxone had no effect. He was given supportive care and woke up 10 hours later, admitting to ingesting kratom and whiskey. Kratom contains compounds that are opioid receptor agonists and can cause respiratory depression, especially in combination with alcohol. Supportive care is the primary treatment for kratom toxicity.
A 55-year-old man was found unconscious at home after ingesting kratom and alcohol. At the emergency department, he was comatose with low vital signs. Treatment with naloxone had no effect. He was given supportive care and woke up 10 hours later, admitting to ingesting kratom and whiskey. Kratom contains compounds that are opioid receptor agonists and can cause respiratory depression, especially in combination with other depressants like alcohol.
The document defines syncope as a transient loss of consciousness due to decreased blood flow to the brain. It classifies syncope into cardiac, reflex/neurocardiogenic, and orthostatic hypotension categories based on etiology. Cardiac syncope can be due to arrhythmias like bradycardia or structural issues like aortic stenosis. Reflex syncope includes vasovagal which can be triggered by emotions or orthostatic stress, and carotid sinus syncope caused by pressure on the carotid sinus. Orthostatic hypotension syncope results from autonomic dysfunction or drugs/illnesses that cause volume depletion.
This document summarizes several experimental animal models used to study seizures and epilepsy. It discusses:
1. Classification of seizures and characteristics of ideal seizure models.
2. Common generalized seizure models including maximal electroshock, pentylenetetrazole, and picrotoxin induced seizures.
3. Models of partial seizures including those induced by topical convulsants, electrical stimulation, and chronic metal implants.
4. Genetic models like photosensitive baboons and audiogenic seizure prone mice strains.
It provides details on methodology, evaluation, and drugs effective in each model. The document aims to describe preclinical tools used in anticonvulsant drug development and mechanistic epilepsy
This document provides an overview of pain management including definitions, classifications, clinical assessment, and various treatment options. It begins with defining acute and chronic pain and outlining the pain pathway. It then discusses taking a history, performing an exam, and ordering investigations to clinically assess pain. Finally, it details the WHO analgesic ladder and various pharmacological and non-pharmacological options for controlling pain, such as oral and parenteral analgesics, adjuvant therapies, and managing side effects.
DENTAL MANAGEMENTS OF PATIENTS WITH GASTROINTESTINAL DISEASE (2).pptxSamuelAgboola11
This document discusses the dental management of patients with various gastrointestinal diseases. It begins by describing the anatomy and functions of the gastrointestinal tract. It then discusses several gastrointestinal diseases including GERD, hiatal hernia, peptic ulcer, inflammatory bowel disease (Crohn's disease and ulcerative colitis), liver cirrhosis, and eating disorders. For each condition, it describes oral manifestations that may be seen and precautions that should be taken during dental treatment. Throughout, it emphasizes the need for dentists to accommodate a patient's underlying systemic disease, avoid drug interactions, and minimize stress when providing care.
DENTAL MANAGEMENT OF PATIENTS WITH REPIRATORY DISEASES 2809-1.pptxSamuelAgboola11
This document discusses the relationship between the respiratory and oral systems. It begins by describing the structures and functions of the respiratory system, including the conducting airways, lungs, muscles of respiration, and control centers in the central nervous system. It then discusses several respiratory diseases like viral upper respiratory infections, asthma, pneumonia, and tuberculosis. For each disease, it covers signs and symptoms, pathogenesis, and dental management considerations. The document emphasizes the importance of oral health in preventing respiratory infections and managing patients with respiratory diseases.
This document provides an introduction to the Book of Revelation. It outlines the learning outcomes which are to have a panoramic view of end time events, an in-depth understanding of Revelation's symbolism, understand God's agenda for the world and how end times events are unfolding, and live in expectation of the rapture. It then gives context on how Revelation was received by John including his exile to the Isle of Patmos where he received visions from Jesus. The document divides Revelation into three parts based on John being told to write what he has seen, what is, and what will be. It also outlines the seven beatitudes or blessings mentioned in Revelation.
Drug-Drug Interactions and the Pharmacotherapy of HIV Infect.pptSamuelAgboola11
This document discusses the interaction between efavirenz (EFV) and rifampin in the treatment of HIV/TB coinfection. While rifampin lowers EFV levels by 25%, studies have found no difference in outcomes when using standard EFV doses of 600 mg daily with rifampin. However, some patients weighing less than 60kg may benefit from an increased EFV dose of 800 mg daily when used with rifampin. Close monitoring of EFV tolerance and response is still recommended when using the standard or increased dose.
This proposal aims to analyze rapport management and relevance in interactions between caregivers and autistic patients in Oyo State, Nigeria. It will use a discourse analysis approach and relevance theory and rapport management theory frameworks. The study aims to identify how relevance and rapport are established and maintained in conversations between caregivers and autistic patients. Audio and video recordings of interactions at autism centers in Ibadan will be collected and categorized based on responses and effects of rapport management. The analysis will provide insight into how autistic patients communicate and manage relationships, which can help caregivers better support them. It will expand knowledge in psycholinguistics, sociolinguistics, discourse analysis and pragmatics regarding autism spectrum disorder.
This document is the notice page for the 9th edition of the Pharmacotherapy Handbook by Barbara G. Wells, Joseph T. DiPiro, Terry L. Schwinghammer, and Cecily V. DiPiro. It notes that medicine is constantly evolving so the information provided may become outdated or inaccurate over time. It advises readers to confirm any medical information with other sources. The notice concludes by listing international publishing locations for McGraw-Hill Education.
This proposal seeks to analyze rapport management and relevance in interactions between caregivers and autistic patients in Oyo State, Nigeria. The study will use discourse analysis to identify relevance and rapport management strategies used. It will examine how communication is built and relationships enhanced. Recordings of interactions at autism centers will be transcribed and categorized based on responses and effects of rapport management. The study aims to expand knowledge of autism and social aspects of language use. Relevance theory and rapport management theory will be applied to transcripts to unravel how talk is managed. Findings may help caregivers better support autistic individuals' interpersonal relationships. The methodology section outlines data collection from recordings and categorization process.
Histamine is a biogenic amine produced by mast cells and basophils through the decarboxylation of histidine. It is involved in various physiological processes through its four receptor subtypes (H1-H4). H1 receptor activation causes vasodilation, smooth muscle contraction, and increased capillary permeability. H2 receptor stimulation increases gastric acid secretion. Histamine is released through immunological, chemical, and mechanical triggers to mediate allergy and inflammation. Antihistamines competitively block H1 and H2 receptors for therapeutic benefit in conditions like allergy, asthma, and peptic ulcer disease.
The document summarizes a study that investigated the neuropharmacological effects of the aqueous extract and fractions of Anchomanes difformis rhizome in mice. The study found that the extract and fractions significantly reduced novelty-induced rearing and grooming behaviors, suggesting sedative and anxiolytic effects. They also reduced immobility time in depression tests and increased time spent in open arms of a maze, indicating antidepressant and anxiolytic properties. Acute toxicity tests found the extract and fractions were safe up to 5000 mg/kg. Overall, the results provide evidence that supports the traditional use of A. difformis for treating mental illness.
This document discusses antiretroviral (ARV) drugs for AIDS care and treatment in Nigeria. It describes the recommended first-line ARV regimen in Nigeria as a combination of three drugs - two nucleoside reverse transcriptase inhibitors (NRTI) like d4T or ZDV plus 3TC, plus a non-nucleoside reverse transcriptase inhibitor (NNRTI) like NVP or EFV. The document provides details on the mechanisms of different drug classes, dosages, administration and storage of specific first-line ARV drugs available in Nigeria according to national guidelines.
This document discusses how environmental and cultural factors influence knowledge construction when interpreting expressions from Yoruba to English. It analyzes 12 Yoruba expressions and their possible interpretations in English, showing how context and the interpreter's knowledge affects meaning. The key findings are that an individual's socialization in their native language determines how deeply they can think and construct knowledge. Directly translating words limits meaning to surface level without considering context. Pragmatics is important for understanding intended meaning based on the situation. Knowledge construction is influenced by social and geographical context rather than isolated meanings.
This document discusses chronic obstructive pulmonary disease (COPD), including emphysema and chronic bronchitis. It states that COPD is the fourth leading cause of death in the US and is often caused by cigarette smoking. Emphysema involves the destruction of alveolar walls leading to enlarged airspaces, and is classified according to its anatomical distribution. Chronic bronchitis clinically involves persistent cough and sputum production for at least three months per year. Both involve chronic inflammation in response to inhaled irritants like cigarette smoke.
This document discusses emerging pharmacotherapeutic agents in the management of obesity. It begins with an overview of obesity, including definitions and classifications based on body mass index. It then discusses the pathophysiology, epidemiology, and etiology of obesity. Current pharmacotherapeutic options for obesity approved by the FDA and emerging agents are outlined. Emerging agents discussed include endocannabinoid system receptor blockers, selective serotonin 2c agonists, peptide YY, glucagon-like peptide-1 analogs, and anti-epileptic agents. The document concludes that the pipeline for new obesity drug development is promising and that developing more potent and better-tolerated agents will help in the management of this growing health problem.
The document describes a study that investigated the neuropharmacological effects of the aqueous extract and fractions of Anchomanes difformis rhizome in mice. The study found that the extract and fractions significantly reduced novelty-induced rearing and grooming behaviors, suggesting sedative and anxiolytic effects. They also reduced immobility time in behavioral despair tests, indicating antidepressant effects. Acute toxicity tests found the extract and fractions were safe up to 5000 mg/kg. Overall, the results provide evidence that supports the traditional use of A. difformis for treating mental illness.
This document summarizes lung cancer, discussing its epidemiology, etiology, pathogenesis, histology, molecular genetics, clinical presentation, and more. It notes that lung cancer is the most common cancer worldwide, with the majority (90-95%) being carcinomas. Cigarette smoking is the main environmental risk factor, though genetic factors also contribute to risk. The document describes the different histological subtypes and their characteristic molecular mutations. Clinical symptoms vary depending on tumor location and spread. Prognosis remains poor with a 5-year survival rate of only 16%.
This document discusses histamine, including its sources, functions, receptors, and modulating drugs. Some key points:
- Histamine is produced in mast cells and basophils from histidine and stored in granules. It is released during allergic reactions and causes effects via four receptor types (H1-H4).
- H1 receptors mediate smooth muscle contraction, vasodilation, increased capillary permeability. H2 receptors stimulate gastric acid secretion.
- Antihistamines competitively block H1 receptors, relieving allergy symptoms. First-generation drugs cross the blood-brain barrier, causing sedation as a side effect.
- Histamine has roles as a neurotransmitter and
This document discusses diseases of the pleura, including pleural effusions, empyema, pneumothorax, haemothorax, chylothorax, and pleural tumors. Pleural effusions can result from increased hydrostatic pressure, increased vascular permeability, decreased osmotic pressure, decreased lymphatic drainage, or inflammation. Empyema is a purulent pleural effusion usually caused by bacterial or fungal infection spreading from the lungs. Pneumothorax is the presence of air in the pleural cavity, often due to lung disease or injury. Primary pleural tumors are rare, but malignant mesothelioma commonly arises from asbestos exposure and has a poor prognosis.
This document discusses the histology and pathology of various lung conditions, including congenital anomalies, pulmonary embolism, and haemorrhage/infarction. It describes congenital anomalies like pulmonary hypoplasia and foregut cysts. Pulmonary embolism is defined as a blood clot traveling to the lungs and is a major cause of death. Risk factors and signs of pulmonary embolism are outlined. Morphological findings of emboli, haemorrhage, and infarction in the lungs are also described.
This document provides guidance on how to effectively read scientific papers. It discusses the different types of scientific papers, the typical organization of a paper, and actions the reader should take. Some key points include: scientific papers usually have a title, abstract, introduction, methods, results, and discussion sections; the reader should first skim the paper and read the abstract to get the main points, then re-read sections more carefully while asking questions; difficulties can arise if papers are poorly written or the author does not clearly explain the purpose and methods. Additional resources on the topic are also referenced.
The document outlines the key steps in a clinical trial process, including study planning, implementation, analysis, and conclusion. As part of study planning, a protocol is developed, an informed consent form and case report forms are finalized, and a database is designed. Sites are then selected and approved by an ethics committee. For implementation, sites are activated, patients are screened and enrolled if eligible, and data is collected and entered into case report forms. The data is then validated, cleaned, and locked for analysis. Statistical analysis is conducted according to a pre-specified plan and results are submitted to regulators. In conclusion, clinical trials require careful planning and implementation to generate accurate data and unambiguous conclusions about test treatments.
8 Surprising Reasons To Meditate 40 Minutes A Day That Can Change Your Life.pptxHolistified Wellness
We’re talking about Vedic Meditation, a form of meditation that has been around for at least 5,000 years. Back then, the people who lived in the Indus Valley, now known as India and Pakistan, practised meditation as a fundamental part of daily life. This knowledge that has given us yoga and Ayurveda, was known as Veda, hence the name Vedic. And though there are some written records, the practice has been passed down verbally from generation to generation.
Local Advanced Lung Cancer: Artificial Intelligence, Synergetics, Complex Sys...Oleg Kshivets
Overall life span (LS) was 1671.7±1721.6 days and cumulative 5YS reached 62.4%, 10 years – 50.4%, 20 years – 44.6%. 94 LCP lived more than 5 years without cancer (LS=2958.6±1723.6 days), 22 – more than 10 years (LS=5571±1841.8 days). 67 LCP died because of LC (LS=471.9±344 days). AT significantly improved 5YS (68% vs. 53.7%) (P=0.028 by log-rank test). Cox modeling displayed that 5YS of LCP significantly depended on: N0-N12, T3-4, blood cell circuit, cell ratio factors (ratio between cancer cells-CC and blood cells subpopulations), LC cell dynamics, recalcification time, heparin tolerance, prothrombin index, protein, AT, procedure type (P=0.000-0.031). Neural networks, genetic algorithm selection and bootstrap simulation revealed relationships between 5YS and N0-12 (rank=1), thrombocytes/CC (rank=2), segmented neutrophils/CC (3), eosinophils/CC (4), erythrocytes/CC (5), healthy cells/CC (6), lymphocytes/CC (7), stick neutrophils/CC (8), leucocytes/CC (9), monocytes/CC (10). Correct prediction of 5YS was 100% by neural networks computing (error=0.000; area under ROC curve=1.0).
Rasamanikya is a excellent preparation in the field of Rasashastra, it is used in various Kushtha Roga, Shwasa, Vicharchika, Bhagandara, Vatarakta, and Phiranga Roga. In this article Preparation& Comparative analytical profile for both Formulationon i.e Rasamanikya prepared by Kushmanda swarasa & Churnodhaka Shodita Haratala. The study aims to provide insights into the comparative efficacy and analytical aspects of these formulations for enhanced therapeutic outcomes.
Muktapishti is a traditional Ayurvedic preparation made from Shoditha Mukta (Purified Pearl), is believed to help regulate thyroid function and reduce symptoms of hyperthyroidism due to its cooling and balancing properties. Clinical evidence on its efficacy remains limited, necessitating further research to validate its therapeutic benefits.
Basavarajeeyam is a Sreshta Sangraha grantha (Compiled book ), written by Neelkanta kotturu Basavaraja Virachita. It contains 25 Prakaranas, First 24 Chapters related to Rogas& 25th to Rasadravyas.
These lecture slides, by Dr Sidra Arshad, offer a quick overview of the physiological basis of a normal electrocardiogram.
Learning objectives:
1. Define an electrocardiogram (ECG) and electrocardiography
2. Describe how dipoles generated by the heart produce the waveforms of the ECG
3. Describe the components of a normal electrocardiogram of a typical bipolar lead (limb II)
4. Differentiate between intervals and segments
5. Enlist some common indications for obtaining an ECG
6. Describe the flow of current around the heart during the cardiac cycle
7. Discuss the placement and polarity of the leads of electrocardiograph
8. Describe the normal electrocardiograms recorded from the limb leads and explain the physiological basis of the different records that are obtained
9. Define mean electrical vector (axis) of the heart and give the normal range
10. Define the mean QRS vector
11. Describe the axes of leads (hexagonal reference system)
12. Comprehend the vectorial analysis of the normal ECG
13. Determine the mean electrical axis of the ventricular QRS and appreciate the mean axis deviation
14. Explain the concepts of current of injury, J point, and their significance
Study Resources:
1. Chapter 11, Guyton and Hall Textbook of Medical Physiology, 14th edition
2. Chapter 9, Human Physiology - From Cells to Systems, Lauralee Sherwood, 9th edition
3. Chapter 29, Ganong’s Review of Medical Physiology, 26th edition
4. Electrocardiogram, StatPearls - https://www.ncbi.nlm.nih.gov/books/NBK549803/
5. ECG in Medical Practice by ABM Abdullah, 4th edition
6. Chapter 3, Cardiology Explained, https://www.ncbi.nlm.nih.gov/books/NBK2214/
7. ECG Basics, http://www.nataliescasebook.com/tag/e-c-g-basics
- Video recording of this lecture in English language: https://youtu.be/kqbnxVAZs-0
- Video recording of this lecture in Arabic language: https://youtu.be/SINlygW1Mpc
- Link to download the book free: https://nephrotube.blogspot.com/p/nephrotube-nephrology-books.html
- Link to NephroTube website: www.NephroTube.com
- Link to NephroTube social media accounts: https://nephrotube.blogspot.com/p/join-nephrotube-on-social-media.html
TEST BANK For An Introduction to Brain and Behavior, 7th Edition by Bryan Kol...rightmanforbloodline
TEST BANK For An Introduction to Brain and Behavior, 7th Edition by Bryan Kolb, Ian Q. Whishaw, Verified Chapters 1 - 16, Complete Newest Versio
TEST BANK For An Introduction to Brain and Behavior, 7th Edition by Bryan Kolb, Ian Q. Whishaw, Verified Chapters 1 - 16, Complete Newest Version
TEST BANK For An Introduction to Brain and Behavior, 7th Edition by Bryan Kolb, Ian Q. Whishaw, Verified Chapters 1 - 16, Complete Newest Version
2. Contents
1. Introduction
2. Definition of Epilepsy and seizures
3. Epidemiology
4. Aetiology
5. Classification
6. Neurobiology of seizures
7. Diagnosis
8. Management/Treatment
9. Economic importance and social
implications.
10. Overview of my project work
3. INTRODUCTION
Etymology: From Greek word epilepsia=“seize” or
“possess”
Believed to a demonic possession
Countered by Hippocrates, 400BC; and Galen, 2nd
Century AD
Associated with the indigent?
Communicable?
4. Definition of epilepsy and seizures
Epilepsy is a disorder of the brain
characterized by an enduring predisposition to
generate epileptic seizures (ILAE and IBE)
Seizures are episodes of abnormal high
frequency electrical discharges of a group of
neurons in the brain.
5. Some causes of seizures
Seizures may be caused by:
Hypoxia
Hypoglycemia
Stroke
Brain tumours
Head trauma
Withdrawal from alcohol
6. Epidemiology
2nd most common neurological disorder(next
to stroke)
0.5-1%(Rang et al, 2007) of world population.
USA=1-2%
7. Aetiology
idiopathic
Environmental perturbation e.g. intrauterine or
neonatal complications.
Traumatic/Symptomatic: due to lesions in the foci.
Cryptogenic
Precipitating factors;
Primary reading epilepsy
Catamenial epilepsy
Photosensitive epilepsy
Emotional stress, hyperventilation etc.
8. Classification
1. Partial(focal) seizures: one
hemisphere only. No loss of
consciousness
2. Generalized seizures: both
hemispheres. Loss of memory. Involves
the whole brain including reticular
system.
9. Partial seizures
a. Simple partial seizures-memory fully is retain
b. Complex partial seizures-altered
consciousness, repetitive behaviour
(automatism)
c. Jacksonian epilepsy-progress along anatomic
lines as discharge spread across the cortex
Partial seizures may evolve into generalized
seizure termed secondarily generalized
seizures.
10. Generalized seizures
1. Primarily generalized tonic-clonic seizures
or grand mal (Yoruba=warapa;
Ogoni(Gokana)=goi)
Brief tonic phase followed by clonic
phase
Last 3-5mins
Confusion, drowsiness after recovery.
11. Generalized seizures
2.Absence seizure or petit mal
Common in children
No falling, short loss of consciousness
Lasts 10-15secs
child concentration is affected
12. Generalized seizures
3.Status epilepticus
A medical emergency
More than 30minutes of continuous
seizure
Recurrent episodes of tonic-clonic
seizures
No full recovery of consciousness
between sequential episodes
13. Classification of Epileptic Seizures
2 major classes (ILAE 1981):
• Partial-onset seizures
– begin in a focal area of the cerebral
cortex
• Generalized-onset seizures
– have an onset recorded
simultaneously in both cerebral
hemispheres.
14. Neurobiology of epilepsy
Neuronal mechanism is poorly understood
Evidence suggest excessive excitatory
neurotransmission mediated by glutamate in
the brain.
• Glutamate=major excitatory neurotransmitter
• Binds to NMDA receptors===> Ca influx; NO
release===>excitation
16. Diagnosis
Seizure must be recurrent with at least 24hrs
interval
Differential diagnosis is made by the use of
electroencephalogram (EEG)
17. Management/treatment
First aid:
Keep patient away from source of injury
Support respiration if suffocating
Allow foams to drip out freely
Take to a doctor
Accurate diagnosis of the type of seizure and
then a rational use of drugs.
18. Management and treatment
• Pharmacological
• Non-pharmacological
Pharmacological: Drugs based on 3 principles
1. Inhibition of excitatory glutamate
neurotransmission
2. Inhibition of Na and Ca
influx==>suppression of repetitive
depolarization
3. Augmentation of GABA inhibitory
neurotransmission
19. Classification of AEDs
• Sodium channel blockers
• Calcium current inhibitors
• Gamma-amino butyric acid (GABA) enhancers
• Glutamate blockers
• Drugs with unknown mechanism of action
20. Sodium Channel Blockers
Sodium Channel Blockers
They prevent the return
of Na channels to the
active state by stabilizing
them in the inactive state.
:. prevent repetitive firing
of the axons
21. Calcium
Channel
Blockers
• The influx of calcium ions produces a partial
depolarization of the membrane which causes an
action potential to be generated in the cell.
• CCBs inhibit T-calcium channels
22. GABA Enhancers
The GABA system
can be enhanced by
• Binding directly to
GABA-A receptors
• Blocking
presynaptic GABA
uptake
• Inhibiting GABA
metabolism by
GABA transaminase
• Increasing GABA
synthesis.
24. The role of astrocytes
Non neuronal cells in the brain
Maintain homeostasis
Found to be morphologically and functionally
altered in different epileptiforms
Target of new drugs
25. Drugs of choice for epilepsy types
Partial and secondarily generalized seizures
1. Carbamazepine………..100-200mg 1-2x(up to 0.8-
1.2g)daily
2. Sodium valproate……..200mg b.i.d (up to 1-2g)
Phenytoin………………….3-4mg/kg b.i.d( up to 200-
400mg)
Lamotrigine………………..200-400mg daily in divided
doses
Gabapentine………………0.9-1.2g daily in divided
doses
Topiramate…………………200-400mg daily in divided
doses
26. Drugs of choice for epilepsy types
Generalized tonic-clonic seizure
1. Sodium valproate…..200mg b.i.d(up to 1-2g)
2. Lamotrigine……………200-400mg in divided doses
Clonazepam…………….2-6mg daily in divided doses
Topiramate……………..200-400mg in divided doses
Carbamazepine……….100-200mg 1-2x (up to0.8-
1.2mg) daily
Phenytoin……………….3-4mg/kg b.i.d(max.200-
400mg)
27. Drugs of choice for epilepsy types
Absence seizure
1. Ethosuximide ………..1-1.5g in divided doses of
500mg
2. Sodium valproate….200mg b.i.d(up to 1-2g)
Clonazepam…………….2-6mg daily in divided
doses
Lamotrigine…………….200-400mg daily in divided
doses
28. Drugs of choice for epilepsy types
Atypical seizures, tonic, myclonic, atonic etc.
1. Sodium valproate…1-2g
2. Clonazepam………..2-6mg daily in divided doses
3. Lamotrigine………..200-400mg
4. Phenytoin…………..200-400mg
5. Ethosuximide……..1-1.5g daily in divided doses
6. Phenobarbital…….60-90mg nocte
29. Drugs of choice for epilepsy types
Status epilepticus
1. Lorazepam……..1mg i.v. repeat over 10mins
2. Clonazepam……1mg i.v. over 30mins
3. Diazepam……….10-20mg i.v. over 2-4mins
Phenytoin……….15-18mg/kg i.v. @ 50mg/min
Phenobarbital….10-20mg/kg i.v. @100mg/min
30. General guide to AED therapy
Start with monotherapy .
Give the most minimal dose possible.
Drug withdrawal should be gradual.
Treatment should span over 2years.
For pregnant women, lowest dose of
monotherapy should be given.
Epileptic fits are self limiting-do not panic.
Epileptics should not operate machines.
31. Non-pharmacological management
Use of ketogenic diet.
Vagus nerve stimulation.
Surgery.
Lifestyle modification/Relaxation.
Alternative therapy: Yoga, Ayurveda,
Acupuncture, etc.
32. Botanicals
• Valerian (European traditional botanical),
• Passiflora incarnata (native North and South
American botanical),
• Kava kava (Pacific native botanical),
• Piper nigrum (traditional Chinese medicine),
and
• Withania somnifera (Ayurvedic medicine)
33. Economic and social implication
Loss of jobs==>poverty.
Career termination==>withdrawal,depression.
Loss of lives==>loss of human resources.
Stigmatization==>feelings of dejection.
34. Overview of my research work
TITLE: The neuropharmacological effects of the
essential oil of Curcuma longa in mice.
The Plant Curcuma longa (Syn Tumeric)
Family; Zingiberaceae
vernacular: ata le funfun---Yoruba
sila kavanda----Gokana(Bodo)
other spp C. domestica, C. xanthorrhiza, C.
zedoaria, C. wenyujin, etc.
37. Ethnomedicinal uses of C.spp.
liver ailments, skin diseases and wound
healing, jaundice, gastric ulcer, joint
inflammation, diabetics, cold and flu
symptoms, biliary disorders, anorexia, cough,
hepatic disorders, rheumatism, and sinusitis
(Jain et al, 1991).
Gonorrhea, peptic ulcers, appetite stimulant,
carminative, astringent and anti-diarrheal
agent, aromatic stomachic and diuretic
38. Ethnosocial uses
• Spice in ‘pepper soup’
• Major component of curry (spice)
• Spice in local drinks called ‘Kunnu’
• Tumeric tea
• Larvicidal
• Insect repellant
39. The scope of my work
Plant collection and identification
Hydrodistillation of the rhizomes to obtain EO
Density determination and formulation of the EO
Acute toxicity studies(LD50 ), (Lorke, 1983) i.p., p.o.
Parameters studied/models
• Novelty induced Behaviours (NIB)-
Rearing/Locomotor
• Anxiolytic test (EPM)
• Anticonvulsant assessment (PTZ/Strychnine)
• Antidepressant activities (Forced Swimming Test)
40. PRELIMINARY RESULTS
1. Density of the essential oil
2. Acute Toxicity/LD50
3. NIB
• Rearing
• Locomotion
4. Anxiolytic
5. Anticonvulsant:-Pro-convulsant
6. Antidepressant
41. RESULTS
• Density: 0.98g/ml
• Acute Toxicity/LD50
P.O.: 693mg/kg
I.P.: 490mg/kg
• Anticonvulsant: Pro-convulsant (≥400 mg/kg)
• Other results are being analysed
42. Discussion/conclusion
• The essentail oil (EO) demonstrated significant
CNS activities-CNS stimulant
• The EO is moderately toxic
• Preliminary results indicate that the EO
possesses anxiolytic, antidepressant and pro-
convulsant effects in mice
• The plant may be further evaluated for other
neuropharmacological activities
• These results may serve as lead-finding for
novel drug discovery
43. References
• Bennet, P. N. and Brown, M.J. Clinical pharmacology 9th edition, Churchhill
Livingstone 2003. Pp. 414-421.
• Bruton, L.L., Lazo, S.J., Parker, L.K. Goodman and Gilman’s the Pharmacological
basis of therapeutics, 11th edition. McGraw-Hill Companies 2007.
• EMDEX, The complete drug formulary for Nigeria’s health professionals,
2008/09 edition. Pp 34-42.
• Katzung, B.G. Basic and clinical pharmacology 10th edition.
• Losi, G., Cammarota, M. and Carmignoto, G. The role of astrologia in
epileptic brain, Frontiers in Pharmacology, 2012.
• Rang, H.P., Dale, M.M., Ritter J.M., Flower, R.J. Rang and Dale’s
pharmacology, 6th edition, Elsevier Inc 2007. Pp 575-587.
• Roth, J.L. Status epilepticus, Medscape 2011.
• Saxena VS, Nadkarni VV. Nonpharmacological treatment of epilepsy. Ann
Indian Acad Neurol 2011; 14:148-152.